Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NVS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Novartis AG (NVS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novartis (NVS) trades at $162.46, up 0.75% today, with a bullish technical signal from moving averages and strong profitability metrics including a 22.5% net income margin. Recent positive Phase III results for remibrutinib in multiple sclerosis trials have boosted sentiment, though the company also paused some autoimmune therapy trials after patient deaths. Revenue grew to $56.67 billion in 2025, with earnings beating expectations in two of the last three quarters.
The outlook is cautiously optimistic, supported by robust cash flow and drug pipeline progress, but risks include clinical trial setbacks and rising debt levels. Analysts are predominantly neutral, with 68% hold ratings, reflecting balanced near-term prospects amid both innovation successes and safety concerns.
Read full analysis

Key Stats

  • Market Cap
    $306.98B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $168.62
  • 52W Low
    $121.80
  • Typical Hold Time
    -
  • Enterprise Value
    $348.31B
  • Div Yield
    2.91%
  • Trading Activity
    -
$160.54
52W Low: $121.8
29 Oct 2025
52W High: $168.62
27 Feb 2026

Track Novartis AG (NVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novartis AG has traded between a low of $121.8 and a high of $168.62, highlighting its annual price range. Buy and sell Novartis AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Most Recent News

Content is generated by Aura AI

Crocs to present at Piper Sandler's 2026 Growth Frontiers Conference on Sept 15

Crocs, Inc., a leading casual footwear company, announced it will present at the Piper Sandler 2026 Growth Frontiers Conference on September 15, 2026, at 11:30 AM ET. The presentation will be available live and as a replay on Crocs' investor relation...

Market News
4 hours ago
PRNewsWire
Neutral
Crocs to present at Piper Sandler's 2026 Growth Frontiers Conference on Sept 15

RBC raises BP target to 700p, citing higher refining margins and debt reduction plans

RBC Capital Markets upgraded BP PLC's target price to 700p and maintained an 'Outperform' rating, driven by improved earnings estimates and expected debt reduction. The planned Castrol deal closure is anticipated to generate $6 billion in cash, aidin...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
RBC raises BP target to 700p, citing higher refining margins and debt reduction plans

Bristol Myers Squibb downgraded to 'Buy' but remains undervalued with strong growth and dividend yield.

Bristol Myers Squibb (BMY) is considered undervalued, trading at a forward P/E of 9.8x with a 3.7% dividend yield. Its growth portfolio now accounts for nearly 60% of revenue, helping offset declines in legacy drugs and supporting 5% year-over-year r...

Analyst Insights
4 hours ago
Seeking Alpha
Bullish
news icon
Bristol Myers Squibb downgraded to 'Buy' but remains undervalued with strong growth and dividend yield.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $306.98B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $168.62
  • 52W Low
    $121.80
  • Typical Hold Time
    -
  • Enterprise Value
    $348.31B
  • Div Yield
    2.91%
  • Trading Activity
    -
$160.54
52W Low: $121.8
29 Oct 2025
52W High: $168.62
27 Feb 2026

Track Novartis AG (NVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novartis AG has traded between a low of $121.8 and a high of $168.62, highlighting its annual price range. Buy and sell Novartis AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!